Endomyocardial Biopsy and Selective Coronary Angiography Are Low-risk Procedures in Pediatric Heart Transplant Recipients: Results of a Multicenter Experience
Overview
Authors
Affiliations
Background: No prior reports documenting the safety and diagnostic yield of cardiac catheterization and endomyocardial biopsy (EMB) in heart transplant recipients include multicenter data.
Methods: Data on the safety and diagnostic yield of EMB procedures performed in heart transplant recipients were recorded in the Congenital Cardiac Catheterization Outcomes Project database at 8 pediatric centers during a 3-year period. Adverse events (AEs) were classified according to a 5-level severity scale. Generalized estimating equation models identified risk factors for high-severity AEs (HSAEs; Levels 3-5) and non-diagnostic biopsy samples.
Results: A total of 2,665 EMB cases were performed in 744 pediatric heart transplant recipients (median age, 12 years [interquartile range, 4.8, 16.7]; 54% male). AEs occurred in 88 cases (3.3%), of which 28 (1.1%) were HSAEs. AEs attributable to EMB included tricuspid valve injury, transient complete heart block, and right bundle branch block. Amongst 822 cases involving coronary angiography, 10 (1.2%) resulted in a coronary-related AE. There were no myocardial perforations or deaths. Multivariable risk factors for HSAEs included fewer prior catheterizations (p = 0.006) and longer case length (p < 0.001). EMB yielded sufficient tissue for diagnosis in 99% of cases. Longer time since heart transplant was the most significant predictor of a non-diagnostic biopsy sample (p < 0.001).
Conclusions: In the current era, cardiac catheterizations involving EMB can be performed in pediatric heart transplant recipients with a low AE rate and high diagnostic yield. Risk of HSAEs is increased in early post-transplant biopsies and with longer case length. Longer time since heart transplant is associated with non-diagnostic EMB samples.
The Role of Magnetic Resonance Imaging in Risk Stratification of Patients with Acute Myocarditis.
Popa A, Cionca C, Agoston R, Rusu F, Tarcau B, Negru A Diagnostics (Basel). 2024; 14(13).
PMID: 39001316 PMC: 11241337. DOI: 10.3390/diagnostics14131426.
Kikano S, Lee S, Dodd D, Godown J, Bearl D, Chrisant M J Heart Lung Transplant. 2023; 43(5):745-754.
PMID: 38141894 PMC: 11070308. DOI: 10.1016/j.healun.2023.12.006.
Richmann D, Gurijala N, Mandell J, Doshi A, Hamman K, Rossi C J Cardiovasc Magn Reson. 2022; 24(1):51.
PMID: 36192743 PMC: 9531384. DOI: 10.1186/s12968-022-00875-z.
Molecular Approaches and Echocardiographic Deformation Imaging in Detecting Myocardial Fibrosis.
Sonaglioni A, Nicolosi G, Rigamonti E, Lombardo M, La Sala L Int J Mol Sci. 2022; 23(18).
PMID: 36142856 PMC: 9501415. DOI: 10.3390/ijms231810944.
Callegari A, Quandt D, Schmitz A, Klingel K, Balmer C, Dave H Int J Environ Res Public Health. 2022; 19(16).
PMID: 36012045 PMC: 9408529. DOI: 10.3390/ijerph191610406.